This inventor holds 2 USPTO granted patents. Top assignee: Cellspect Co., Ltd.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Chiharu Yoshimoto: Innovator in Ovarian Endometriosis Diagnostics
Introduction
Chiharu Yoshimoto is a notable inventor based in Kashiwara, Japan. He has made significant contributions to the field of medical diagnostics, particularly concerning ovarian endometriosis. With a total of two patents to his name, Yoshimoto is recognized for his innovative approaches to diagnosing cancerous conditions.
Latest Patents
Yoshimoto's latest patents include a data acquisition method for determining the likelihood that an ovarian endometriotic cyst is cancerous, as well as a diagnostic device for the same purpose. The problem addressed by these inventions is the need for a reliable method to acquire data that can serve as an index for assessing the cancerous potential of ovarian endometriosis cysts. The solution involves a method that includes an iron concentration measurement step, which measures the iron concentration in the cystic fluid of the ovarian endometriosis cyst. The diagnostic device is equipped with an iron concentration measurement unit, enabling accurate assessments of the cyst's characteristics.
Career Highlights
Chiharu Yoshimoto is affiliated with Cellspect Co., Ltd., where he continues to develop innovative solutions in the medical field. His work has the potential to significantly impact the diagnosis and treatment of ovarian endometriosis, providing healthcare professionals with essential tools for patient care.
Collaborations
Yoshimoto collaborates with talented individuals such as Hiroshi Kobayashi and Junko Takahama, who contribute to the advancement of his projects and innovations.
Conclusion
Chiharu Yoshimoto's contributions to the field of ovarian endometriosis diagnostics highlight the importance of innovation in medical technology. His patents reflect a commitment to improving patient outcomes through advanced diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile